Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.11%67.47B | 13.23%61.84B | 9.18%15.71B | 7.71%15.18B | 18.10%15.93B | 18.79%15.02B | 22.43%54.61B | 27.41%14.39B | 21.45%14.1B | 22.64%13.49B |
| Cost of revenue | 7.12%27.25B | 8.02%25.44B | 2.13%6.35B | -1.76%6.21B | 14.13%6.56B | 20.03%6.33B | 24.25%23.55B | 28.54%6.21B | 25.87%6.32B | 22.79%5.74B |
| Gross profit | 10.50%40.22B | 17.17%36.4B | 14.54%9.36B | 15.39%8.98B | 21.05%9.37B | 17.90%8.69B | 21.09%31.06B | 26.56%8.17B | 18.08%7.78B | 22.53%7.74B |
| Operating expense | 6.19%33.43B | 7.34%31.48B | 6.04%8.19B | 2.04%7.63B | 9.92%8.01B | 11.85%7.64B | 15.51%29.33B | 18.69%7.72B | 16.53%7.48B | 17.72%7.29B |
| Staff costs | 9.37%17.7B | 9.51%16.19B | ---- | ---- | ---- | ---- | 15.38%14.78B | ---- | ---- | ---- |
| Rent and land expenses | 3.59%3.66B | 2.77%3.53B | ---- | ---- | ---- | ---- | 13.95%3.44B | ---- | ---- | ---- |
| Other operating expenses | 2.61%12.07B | 5.85%11.76B | ---- | ---- | ---- | ---- | 16.19%11.11B | ---- | ---- | ---- |
| Operating profit | 38.07%6.79B | 183.28%4.92B | 160.71%1.17B | 351.86%1.34B | 200.59%1.36B | 94.63%1.05B | 554.79%1.74B | 999.86%449.01M | 77.52%296.86M | 259.31%452.32M |
| Net non-operating interest income (expenses) | 117.39%4M | 52.30%-23M | 79.62%-2.38M | 58.95%-4.63M | 50.14%-5.75M | 25.53%-10.25M | 22.85%-48.22M | 22.11%-11.65M | 28.90%-11.27M | 27.46%-11.53M |
| Non-operating interest income | 14.06%73M | 44.02%64M | 44.72%17.4M | 47.81%17.6M | 39.71%15.79M | 43.51%13.21M | 42.57%44.44M | 51.44%12.02M | 51.78%11.91M | 50.57%11.3M |
| Non-operating interest expense | -20.69%69M | -6.10%87M | -16.48%19.78M | -4.10%22.23M | -5.66%21.54M | 2.14%23.47M | -1.08%92.65M | 3.39%23.68M | -2.19%23.18M | -2.44%22.83M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -6.07%-297M | -41.03%-280M | 50.65%-240.57M | 95.10%-2.43M | 5.43%-5.64M | -109.10%-31.36M | -114.08%-198.54M | -1,183.92%-487.5M | -105.43%-49.52M | -103.50%-5.96M |
| Less:Other special charges | -8.82%31M | 112.46%34M | -106.18%-5.43M | 239.03%2.43M | 138.68%5.64M | 109.10%31.36M | 85.87%-272.91M | 117.45%87.86M | 99.81%-1.75M | 93.32%-14.58M |
| Less:Write off | 8.13%266M | -47.82%246M | -38.45%246M | ---- | ---- | ---- | -9.39%471.45M | -12.84%399.64M | 269.61%51.26M | ---- |
| Other non-operating income (expenses) | -13.17%145M | 134.99%167M | 143.28%35.9M | 42.05%42.1M | 468.43%50.72M | 115.66%38.28M | 64.34%71.07M | 200.17%14.76M | 61.59%29.64M | -72.36%8.92M |
| Income before tax | 38.98%6.64B | 206.12%4.78B | 2,808.59%958.57M | 419.15%1.38B | 214.59%1.4B | 17.81%1.05B | -5.76%1.56B | -2.23%-35.39M | -75.42%265.71M | 41.94%443.75M |
| Income tax | 10.81%1.68B | 176.88%1.52B | 439.51%146.59M | 331.50%453.41M | 192.84%512.57M | 30.06%404.44M | 54.53%547.9M | 72.29%-43.18M | -68.07%105.08M | 181.50%175.03M |
| Net income | 52.05%4.96B | 221.94%3.26B | 10,327.35%811.98M | 476.47%926.02M | 228.75%883.41M | 11.20%640.59M | -22.18%1.01B | -93.57%7.79M | -78.63%160.64M | 7.29%268.72M |
| Net income continuous operations | 52.08%4.96B | 221.94%3.26B | 10,327.34%811.98M | 476.47%926.02M | 228.75%883.41M | 11.20%640.59M | -22.18%1.01B | -93.57%7.79M | -78.63%160.64M | 7.29%268.72M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 52.05%4.96B | 221.94%3.26B | 10,327.35%811.98M | 476.47%926.02M | 228.75%883.41M | 11.20%640.59M | -22.18%1.01B | -93.57%7.79M | -78.63%160.64M | 7.29%268.72M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 52.05%4.96B | 221.94%3.26B | 10,327.35%811.98M | 476.47%926.02M | 228.75%883.41M | 11.20%640.59M | -22.18%1.01B | -93.57%7.79M | -78.63%160.64M | 7.29%268.72M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 52.06%280.95 | 221.94%184.76 | 10,354.55%46 | 476.12%52.42 | 228.88%50.055 | 11.20%36.285 | -22.18%57.39 | -93.59%0.44 | -78.63%9.0988 | 7.30%15.2199 |
| Diluted earnings per share | 52.06%280.95 | 221.94%184.76 | 10,351.45%45.9864 | 476.12%52.42 | 228.77%50.0385 | 11.20%36.285 | -22.18%57.39 | -93.59%0.44 | -78.63%9.0988 | 7.30%15.2199 |
| Dividend per share | 16.67%70 | 700.00%60 | 900.00%50 | 0 | 300.00%10 | 0 | -25.00%7.5 | 0.00%5 | 0 | -50.00%2.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |